HMD Labs achieves unqualified SOC 2 security audit
SAN FRANCISCO, CA (June 23, 2022) -- San Francisco-based HMD Labs, a leading developer of technology solutions for medical device firms, today announced the company has successfully completed a SOC 2 Type II audit for its NeuronSphere® Platform. The audit is in accordance with American Institute of Certified Public Accountants (AICPA) standards for Service Organization Control for Service Organizations (SOC 2), also known as SSAE 18.
NeuronSphere is a next-generation data ecosystem that provides medical device companies with turnkey access to enterprise capabilities such as infrastructure, ingestion, analytics, machine learning and data pipelines, at a fraction of the time and complexity. The result is a reliable, scalable, and compliant data ecosystem fully configured for medical device development use cases.
SOC 2 is an internationally recognized certification developed by the AICPA. It acts as third-party assurance to verify that a service provider is committed to following the highest standards of security when it comes to managing customer data. The reports focus on controls grouped into five categories called Trust Service Principles: security, availability, confidentiality, processing, integrity and privacy. A Type II attestation means that HMD Labs' security procedures have been actively monitored over a period of time by independent auditors to ensure accuracy and effectiveness.
“The HMD motto is ‘When it comes to being secure: we say what we do, we do what we say, and we can prove it,” said Michelle Taub, Director of Quality and Compliance. “AICPA certification and SOC compliance means that the ways in which we manage our data has withstood the most rigorous security audit in the industry. An unqualified opinion on a SOC 2 Type II audit report demonstrates to HMD Labs' current and future customers that we manage their data with the highest standard of security and compliance.”
NeuronSphere provides the controls, security, and compliance needed for medical device development. In addition, it accelerates value cycles from high-complexity data, optimizing cost and performance by enabling all aspects of a Data Mesh architecture. NeuronSphere streamlines compliance with FDA, GxP, SaMD, GDPR, and global data sovereignty and tenancy demands, while ensuring companies can deliver with agility and maintain ironclad control of the cloud data platform.
About HMD Labs
HMD Labs creates solutions for tomorrow’s AI/ML enabled medical device companies. Their flagship solution, NeuronSphere®, provides extensible and integrated components that allow medical device companies to glean exponential value from large, complex data sets while adhering to compliance and security requirements. This fully managed ecosystem provides a complete toolkit to expedite research and development, and to bring innovative products to market quickly. For more information about HMD Labs and NeuronSphere®, visit https://www.neuronsphere.io.